newsfilter
← Latest News
Business Wire·

Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Directors

PITTSBURGH, Pa.--(BUSINESS WIRE)--Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed M. Michelle Berrey, M.D., M.P.H. and Annamaria T. Kausz, M.D., M.S. as members of the company’s Board of Directors.